The Alzheimer's Association predicts that by 2050 ... while taking advantage of current treatments. "I always say that I think these drugs are a major step forward, but they're not the answer.

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

a timely and accurate diagnosis can improve patients’ chances to benefit from current treatments and participate in clinical trials. We believe accelerating the diagnosis of Alzheimer’s can ...

A groundbreaking discovery by scientists at Japan’s RIKEN Center for Brain Science has revealed an unexpected link between dopamine and Alzheimer’s disease. This revelation could mark a major ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

Improve doctors’ ability to tailor treatment doses to an individual’s needs. Provide new ways to measure the effects of drugs used to treat dementia. Sleep disturbances are common in dementia and can ...

"It will open the door to interventions used very early in the course of disease that are better targeted than current treatments. Alzheimer's can cause memory problems, confusion and ...

(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease ...